Search

Showing total 39 results

Search Constraints

Start Over You searched for: Topic t cells Remove constraint Topic: t cells Publication Year Range This year Remove constraint Publication Year Range: This year Language english Remove constraint Language: english
39 results

Search Results

1. Wenyang-Tianjing-Jieyu Decoction Improves Depression Rats of Kidney Yang Deficiency Pattern by Regulating T Cell Homeostasis and Inflammation Level.

2. T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies.

3. Macrophage barrier in the tumor microenvironment and potential clinical applications.

4. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.

5. Epstein-Barr Virus Lytic Transcripts Correlate with the Degree of Myocardial Inflammation in Heart Failure Patients.

6. A low power static noise margin enhanced reliable 8 T SRAM cell.

7. The Role of Mesenchymal Stromal Cells in the Treatment of Rheumatoid Arthritis.

8. Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy.

9. Pericytes Are Immunoregulatory Cells in Glioma Genesis and Progression.

10. Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implications.

11. TripHLApan: predicting HLA molecules binding peptides based on triple coding matrix and transfer learning.

12. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.

13. Exploring the efficacy and safety of anti-BCMA chimeric antigen receptor T-cell therapy for multiple myeloma: Systematic review and meta-analysis.

14. A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets.

15. Dose-finding based on feasibility and late-onset toxicity in adoptive cell therapy trials.

16. Quantifying the HIV reservoir with dilution assays and deep viral sequencing.

17. CAR‐T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives.

18. Traditional Chinese Medicine for Cancer Treatment.

19. Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?

20. Autoimmunity and Autoinflammation: Relapsing Polychondritis and VEXAS Syndrome Challenge.

21. Bistability and Bifurcations of Tumor Dynamics with Immune Escape and the Chimeric Antigen Receptor T-Cell Therapy.

22. Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.

23. B cells in head and neck squamous cell carcinoma: current opinion and novel therapy.

24. Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes.

25. A Micrometric Transformer: Compositional Nanoshell Transformation of Fe3+‐Trimesic‐Acid Complex with Concomitant Payload Release in Cell‐in‐Catalytic‐Shell Nanobiohybrids.

26. The expression and significance of PD‐L1 in condyloma acuminatum.

27. Identification and Functional Characterization of PI3K/Akt/mTOR Pathway-Related lncRNAs in Lung Adenocarcinoma: A Retrospective Study.

28. The Roles of Various Immune Cell Populations in Immune Response against Helminths.

29. Molecular Characteristics, Functional Definitions, and Regulatory Mechanisms for Cross-Presentation Mediated by the Major Histocompatibility Complex: A Comprehensive Review.

30. Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2.

31. First person - Fabrizia Zevolini.

32. CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up.

33. Electrochemical immuno-biosensors for the detection of the tumor marker alpha-fetoprotein: A review.

34. Circuit-level design of radiation tolerant memory cell.

35. FOXP3 (in)stability and cancer immunotherapy.

36. The interaction between the costimulatory molecules CD80/86 and CD28 contributed to CD4+ T lymphocyte activation in flounder (Paralichthys olivaceus).

37. ESTABLISHMENT OF A DOUBLE-HUMANIZED MOUSE MODEL USING PATIENT-DERIVED XENOGRAFT BLADDER CANCER TUMOR CELL LINE AND HUMAN γδ T-CELLS.

38. Azo-based hypoxic-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug combined with vascular disrupting agent nanoparticles for tumor-selective glutamine metabolism blockade.

39. Inhibitory receptors and checkpoints on NK cells: Implications for cancer immunotherapy.